| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 301,3 k € | -0.1% | 301,7 k € | -9.7% | 334,1 k € | +18.7% | 281,6 k € | +8.6% | 259,4 k € | +4.6% | 248,1 k € | -0.2% | 248,6 k € | |
| EBITDA | 301,1 k € | -0.1% | 301,4 k € | -9.7% | 333,9 k € | +18.7% | 281,4 k € | +8.6% | 259,1 k € | +4.6% | 247,9 k € | -0.2% | 248,4 k € | |
| Operating profit | 301,1 k € | -0.1% | 301,4 k € | -9.7% | 333,9 k € | +18.7% | 281,4 k € | +8.6% | 259,1 k € | +4.6% | 247,9 k € | -0.2% | 248,4 k € | |
| Profit/loss | 187,0 k € | +1.1% | 185,0 k € | -13.2% | 213,1 k € | +20.9% | 176,3 k € | +7.9% | 163,4 k € | +10.4% | 148,1 k € | +9.3% | 135,5 k € | |
| Equity | 1,2 M € | +18.0% | 1,0 M € | +21.6% | 854,9 k € | +33.2% | 641,9 k € | +37.9% | 465,6 k € | +54.1% | 302,1 k € | +96.1% | 154,0 k € | |
| Total assets | 2,7 M € | -2.4% | 2,8 M € | +0.9% | 2,7 M € | +2.5% | 2,7 M € | -3.0% | 2,7 M € | +0.3% | 2,7 M € | +3.7% | 2,6 M € | |
| Cash | 85,9 k € | -12.2% | 97,8 k € | +507.9% | 16,1 k € | -70.6% | 54,8 k € | -62.6% | 146,7 k € | -3.9% | 152,6 k € | +178.1% | 54,9 k € | |
| Debts | 1,5 M € | -14.8% | 1,7 M € | -8.6% | 1,9 M € | -7.3% | 2,0 M € | -11.4% | 2,3 M € | -6.8% | 2,4 M € | -2.0% | 2,5 M € | |
Private limited company · Grobbendonk · incorporated on 30/11/2017
Private limited company profitable and well capitalised. Cash position declining (-12.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Lira Pharma is a Private limited company incorporated in 2017. Its main activity is: Activities of holding companies. Its registered office is in Grobbendonk.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.